Monitoring quality of life in patients with haematological malignancies
Intended for healthcare professionals
Clinical Previous     Next

Monitoring quality of life in patients with haematological malignancies

Lesley Grimmer Clinical nurse specialist in haematology, Department of clinical haematology at the Queen Elizabeth Hospital, King’s Lynn, Norfolk
Claire Atterbury Clinical nurse specialist in haematology and transfusion, Department of haematology at the Queen Elizabeth Hospital, King’s Lynn, Norfolk
Jane Keidan Consultant haematologist, Queen Elizabeth Hospital, King’s Lynn, Norfolk

Intensive treatment for haematological malignancies can have an enormous effect on the patient’s quality of life (QoL) and may lead to psychosocial problems during and after treatment. This paper describes a method of monitoring QoL in patients receiving intensive chemotherapy to enable prompt medical, social and/or psychological intervention where necessary. A structured approach to psychosocial assessment revealed that the HAD scores of Hodgkin’s patients were significantly higher compared with cases of other haematological malignancies. Hodgkin’s disease patients are now automatically assessed formally by a clinical psychologist at diagnosis.

Cancer Nursing Practice. 3, 7, 24-30. doi: 10.7748/cnp2004.09.3.7.24.c134

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or